Veerhealth Care Limited Share Price & Stock Analysis

Veerhealth Care Limited (BSE: 511523) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹105 Cr, it ranks #3,206 by market cap among the 6,197 Indian listed companies on FinBizNet, and #44 of 63 in Pharmaceuticals. At ₹52.38 (as of 16 Nov 2026), the share price is 1.0% below its 52-week high of ₹52.90 and 208.8% above its 52-week low of ₹16.96. The share price is up 189.4% over one year and up 12.6% over three months.

Key Metrics

Current Price₹52.38
Market Cap₹105 Cr
BSE Code511523
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio192.6
Return on Equity1.78%
Return on Assets2.10%
52-Week Range₹16.96 – ₹52.90
1-Year Price Change+189.4%
3-Month Price Change+12.6%
Beta (1Y)0.31
HeadquartersMumbai, Maharashtra
Websiteveerhealthcare.net

Shareholding and Delivery

Delivery averaged 80.6% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Veerhealth Care Limited

Veerhealth Care Limited engages in manufacturing, marketing, and trading of ayurvedic medicines in India. The company offers skincare products, such as creams, face serum, facewash, toners, lip balms, and scrubs; body care products, including bodywash, bath salts, lotions, handwash, and soaps; hair oils, hair combs, hair serum, shampoos, and conditioners; Ayurvedic Wellness, such as syrups, tablets, and pain relief oils; toothpastes; body and beard care products; gifting products; and accessories. It also provides plastic packaging material, including bottles, caps, and enclosures for use in various industries comprising food, cosmetics, household cleaning, pharmaceuticals, and others. The company also sells its products online. It exports its products. The company was formerly known as Niyati Industries Limited and changed its name to Veerhealth Care Limited in September 2013. Veerhealth Care Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Products and Services

1. Sale/Trading in Shares-This segment engages in the trading of pharmaceutical products. It offers a range of ayurvedic and generic medicines covering tablet, capsule, power, liquid, and ointments and cosmetics. 2. Corporate-This segment engages in dealing and trading in shares, securities, debentures, and other investments in India. 3. Segment Adjustment-0 4. Other-0

Business Segments

1. Ayurved Pharma Products-100%

Veerhealth Care Limited vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Veerhealth Care Limited₹105 Cr192.61.78%—+189.4%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Veerhealth Care Limited?

Veerhealth Care Limited is trading at ₹52.38, with a market capitalisation of ₹105 Cr.

Which sector does Veerhealth Care Limited belong to?

Veerhealth Care Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Veerhealth Care Limited?

Veerhealth Care Limited has a P/E of 192.6 and a return on equity of 1.78%.

What is the stock symbol of Veerhealth Care Limited?

Veerhealth Care Limited is listed on the BSE under the scrip code 511523.

How has Veerhealth Care Limited's share price moved over the past year?

Veerhealth Care Limited's share price is up 189.4% over one year and up 12.6% over three months. Its 52-week range is ₹16.96 to ₹52.90.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.